Company profile: Diagenode
1.1 - Company Overview
Company description
- Provider of instruments and reagents for life science research and molecular diagnostics, including ultrasound-based sample preparation and DNA/RNA shearing (Bioruptor), high molecular weight DNA shearing for long-read sequencing (Megaruptor), automation for ChIP and epigenetic assays (IP-Star), epigenomics profiling services, and ChIP and DNA methylation kits.
Products and services
- Bioruptor Sonication: Ultrasound-based, laboratory-grade device that shears chromatin, DNA, and RNA and disrupts cells and tissues, delivering high-quality sample preparation
- IP-Star Automation: High-throughput automated platform for chromatin immunoprecipitation (ChIP) and other epigenetic assays, streamlining workflows and increasing throughput in epigenetics experiments
- Megaruptor: Research-grade instrument engineered for shearing high molecular weight DNA, delivering reproducible fragmentation specifically for long-read sequencing applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Diagenode
Biohit Healthcare
HQ: Finland
Website
- Description: Provider of biotech and diagnostics products for healthcare and research, developing, manufacturing, and marketing solutions while distributing biomedical and gastrointestinal diagnostic devices. Offerings include GastroPanel, a blood-based test for stomach lining assessment; Acetium lozenges and capsules for digestive health and smoking cessation; and the FAEX Sample System for stool sample collection and handling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biohit Healthcare company profile →
Microbia
HQ: United States
Website
- Description: Provider of industrial biotechnology, developing, producing, and commercializing fermentation-based specialty ingredients and biomaterials, including carotenoids, biopolymers, and other biomaterials; maintains a strategic alliance with Tate & Lyle Investments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbia company profile →
Champions Oncology
HQ: United States
Website
- Description: Provider of advanced technology solutions and services for personalizing the development and use of oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Champions Oncology company profile →
Helapet
HQ: United Kingdom
Website
- Description: Provider of medical and cleanroom consumables as a manufacturer and distributor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helapet company profile →
ActivX Biosciences
HQ: United States
Website
- Description: Provider of biopharmaceutical discovery and development of highly selective, best-in-class small molecule drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ActivX Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Diagenode
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Diagenode
2.2 - Growth funds investing in similar companies to Diagenode
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Diagenode
4.2 - Public trading comparable groups for Diagenode
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →